Page last updated: 2024-08-21

adamantane and Pulmonary Disease, Chronic Obstructive

adamantane has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Azoulay, L; Bouganim, N; Platt, RW; Rouette, J; Yin, H; Yu, OHY1

Other Studies

1 other study(ies) available for adamantane and Pulmonary Disease, Chronic Obstructive

ArticleYear
Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes.
    Diabetic medicine : a journal of the British Diabetic Association, 2020, Volume: 37, Issue:5

    Topics: Adamantane; Aged; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Incidence; Incretins; Linagliptin; Liraglutide; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Pulmonary Disease, Chronic Obstructive; Risk Factors; Sitagliptin Phosphate; Smoking

2020